CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,539
- in 2 filings, $289K under 10b5-1 plans
Net −$288,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-11 | YANG MICHAEL J. Director | Grant or award · Stock Option (Right to Buy) | +11,279 | 11,279 | ||
| 2025-06-11 | CHRISTIE CHRISTOPHER Director | Grant or award | +6,163 | 16,654 | ||
| 2025-06-11 | CHRISTIE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +11,279 | 11,279 | ||
| 2025-06-11 | Young Alethia Director | Grant or award | +6,163 | 11,393 | ||
| 2025-06-11 | Young Alethia Director | Grant or award · Stock Option (Right to Buy) | +11,279 | 11,279 | ||
| 2025-06-11 | Brege Laura Director | Grant or award | +6,163 | 23,715 | ||
| 2025-06-11 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +11,279 | 11,279 | ||
| 2025-06-04 | RIKER LAUREN Senior Vice President, Finance | Sale | −5,578.34 | $26.21 | $146K | 59,564 |
| 2025-06-04 | WILLIAMS KRISTEN Chief Administrative Officer | Sale | −14,376 | $26.24 | $377K | 161,574 |
| 2025-06-03 | RIKER LAUREN Senior Vice President, Finance | Shares withheld for taxes | −3,374 | $26.40 | $89K | 65,142.34 |
| 2025-06-03 | WILLIAMS KRISTEN Chief Administrative Officer | Shares withheld for taxes | −6,162 | $26.40 | $163K | 175,950 |
| 2025-06-03 | SLONIN JONATHAN Chief Medical Officer | Shares withheld for taxes | −5,084 | $26.40 | $134K | 181,959.51 |
| 2025-02-04 | Teehan Brendan Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +99,500 | $26.59 | $2.6M | 99,500 |
| 2025-02-01 | SLONIN JONATHAN Chief Medical Officer | Grant or award | +93,600 | 187,043.51 | ||
| 2025-02-01 | WILLIAMS KRISTEN Chief Administrative Officer | Grant or award | +79,200 | 182,112 | ||
| 2025-02-01 | Lee Frank D. Chief Executive Officer | Grant or award | +350,000 | 448,409 | ||
| 2025-02-01 | Teehan Brendan Chief Commercial Officer | Grant or award | +54,000 | 54,000 | ||
| 2025-02-01 | RIKER LAUREN Senior Vice President, Finance | Grant or award | +30,600 | 68,516.34 | ||
| 2025-01-06 | SLONIN JONATHAN Chief Medical Officer | Sale 10b5-1 | −879 | $18.40 | $16K | 93,443.51 |
| 2025-01-02 | Lee Frank D. Chief Executive Officer | Shares withheld for taxes | −9,375 | $18.33 | $172K | 98,409 |
Page 5 of 9 · 161 trades